A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acalabrutinib
Related studies linked through entity extraction aliases.
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
- Status
- RECRUITING
- Phase
- NA
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom
- Status
- RECRUITING
- Phase
- N/A
A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Effect of Pharmacokinetics (PK) of Acalabrutinib and Its Active Metabolite (ACP-5862) When Administered Alone and With Moderate CYP3A4 Inhibitors Fluconazole or Isavuconazole in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Preventing Anaphylaxis With Acalabrutinib
- Status
- COMPLETED
- Phase
- PHASE2
Public Health Emergency: SOLIDARITY TRIAL Philippines
- Status
- COMPLETED
- Phase
- NA
Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial
- Status
- RECRUITING
- Phase
- PHASE2
Acalabrutinib in CNSL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2